The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Rhabdoid Tumor

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Rhabdoid Tumor


High impact information on Rhabdoid Tumor


Chemical compound and disease context of Rhabdoid Tumor


Biological context of Rhabdoid Tumor


Anatomical context of Rhabdoid Tumor


Gene context of Rhabdoid Tumor


Analytical, diagnostic and therapeutic context of Rhabdoid Tumor


  1. Epigenetic repression of RASSF1A but not CASP8 in supratentorial PNET (sPNET) and atypical teratoid/rhabdoid tumors (AT/RT) of childhood. Mühlisch, J., Schwering, A., Grotzer, M., Vince, G.H., Roggendorf, W., Hagemann, C., Sörensen, N., Rickert, C.H., Osada, N., Jürgens, H., Frühwald, M.C. Oncogene (2006) [Pubmed]
  2. Alteration of hSNF5/INI1/BAF47 detected in rhabdoid cell lines and primary rhabdomyosarcomas but not Wilms' tumors. DeCristofaro, M.F., Betz, B.L., Wang, W., Weissman, B.E. Oncogene (1999) [Pubmed]
  3. Germline INI1 mutation in a patient with a central nervous system atypical teratoid tumor and renal rhabdoid tumor. Biegel, J.A., Fogelgren, B., Wainwright, L.M., Zhou, J.Y., Bevan, H., Rorke, L.B. Genes Chromosomes Cancer (2000) [Pubmed]
  4. Exon scanning for mutations of the NF2 gene in pediatric ependymomas, rhabdoid tumors and meningiomas. Slavc, I., MacCollin, M.M., Dunn, M., Jones, S., Sutton, L., Gusella, J.F., Biegel, J.A. Int. J. Cancer (1995) [Pubmed]
  5. Immunohistochemical evaluation of hepatoblastomas with use of the hepatocyte-specific marker, hepatocyte paraffin 1, and the polyclonal anti-carcinoembryonic antigen. Fasano, M., Theise, N.D., Nalesnik, M., Goswami, S., Garcia de Davila, M.T., Finegold, M.J., Greco, M.A. Mod. Pathol. (1998) [Pubmed]
  6. Cancer-associated mutations in chromatin remodeler hSNF5 promote chromosomal instability by compromising the mitotic checkpoint. Vries, R.G., Bezrookove, V., Zuijderduijn, L.M., Kia, S.K., Houweling, A., Oruetxebarria, I., Raap, A.K., Verrijzer, C.P. Genes Dev. (2005) [Pubmed]
  7. Inactivation of the Snf5 tumor suppressor stimulates cell cycle progression and cooperates with p53 loss in oncogenic transformation. Isakoff, M.S., Sansam, C.G., Tamayo, P., Subramanian, A., Evans, J.A., Fillmore, C.M., Wang, X., Biegel, J.A., Pomeroy, S.L., Mesirov, J.P., Roberts, C.W. Proc. Natl. Acad. Sci. U.S.A. (2005) [Pubmed]
  8. Genetic ablation of Cyclin D1 abrogates genesis of rhabdoid tumors resulting from Ini1 loss. Tsikitis, M., Zhang, Z., Edelman, W., Zagzag, D., Kalpana, G.V. Proc. Natl. Acad. Sci. U.S.A. (2005) [Pubmed]
  9. Cloning of P2XM, a novel human P2X receptor gene regulated by p53. Urano, T., Nishimori, H., Han, H., Furuhata, T., Kimura, Y., Nakamura, Y., Tokino, T. Cancer Res. (1997) [Pubmed]
  10. Midkine induces tumor cell proliferation and binds to a high affinity signaling receptor associated with JAK tyrosine kinases. Ratovitski, E.A., Kotzbauer, P.T., Milbrandt, J., Lowenstein, C.J., Burrow, C.R. J. Biol. Chem. (1998) [Pubmed]
  11. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors. Biegel, J.A., Tan, L., Zhang, F., Wainwright, L., Russo, P., Rorke, L.B. Clin. Cancer Res. (2002) [Pubmed]
  12. Antitumor activity of gefitinib in malignant rhabdoid tumor cells in vitro and in vivo. Kuwahara, Y., Hosoi, H., Osone, S., Kita, M., Iehara, T., Kuroda, H., Sugimoto, T. Clin. Cancer Res. (2004) [Pubmed]
  13. Drug resistance in malignant rhabdoid tumor cell lines. Rosson, G.B., Vincent, T.S., Oswald, B.W., Wright, C.F. Cancer Chemother. Pharmacol. (2002) [Pubmed]
  14. Primary extracranial rhabdoid tumors. Clinicopathologic features and response to ifosfamide. Gururangan, S., Bowman, L.C., Parham, D.M., Wilimas, J.A., Rao, B., Pratt, C.B., Douglass, E.C. Cancer (1993) [Pubmed]
  15. Rhabdoid tumor growth is inhibited by flavopiridol. Smith, M.E., Cimica, V., Chinni, S., Challagulla, K., Mani, S., Kalpana, G.V. Clin. Cancer Res. (2008) [Pubmed]
  16. The tumor suppressor hSNF5/INI1 modulates cell growth and actin cytoskeleton organization. Medjkane, S., Novikov, E., Versteege, I., Delattre, O. Cancer Res. (2004) [Pubmed]
  17. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Biegel, J.A., Zhou, J.Y., Rorke, L.B., Stenstrom, C., Wainwright, L.M., Fogelgren, B. Cancer Res. (1999) [Pubmed]
  18. P16INK4a is required for hSNF5 chromatin remodeler-induced cellular senescence in malignant rhabdoid tumor cells. Oruetxebarria, I., Venturini, F., Kekarainen, T., Houweling, A., Zuijderduijn, L.M., Mohd-Sarip, A., Vries, R.G., Hoeben, R.C., Verrijzer, C.P. J. Biol. Chem. (2004) [Pubmed]
  19. Absence of expression of SMARCB1/INI1 in malignant rhabdoid tumors of the central nervous system, kidneys and soft tissue: an immunohistochemical study with implications for diagnosis. Sigauke, E., Rakheja, D., Maddox, D.L., Hladik, C.L., White, C.L., Timmons, C.F., Raisanen, J. Mod. Pathol. (2006) [Pubmed]
  20. The survivin:fas ratio in pediatric renal tumors. Takamizawa, S., Scott, D., Wen, J., Grundy, P., Bishop, W., Kimura, K., Sandler, A. J. Pediatr. Surg. (2001) [Pubmed]
  21. Rhabdoid tumors of the kidney contain mesenchymal specific and epithelial specific intermediate filament proteins. Vogel, A.M., Gown, A.M., Caughlan, J., Haas, J.E., Beckwith, J.B. Lab. Invest. (1984) [Pubmed]
  22. Immunohistochemistry of primary central nervous system malignant rhabdoid tumors: report of five cases and review of the literature. Behring, B., Brück, W., Goebel, H.H., Behnke, J., Pekrun, A., Christen, H.J., Kretzschmar, H.A. Acta Neuropathol. (1996) [Pubmed]
  23. A masked NES in INI1/hSNF5 mediates hCRM1-dependent nuclear export: implications for tumorigenesis. Craig, E., Zhang, Z.K., Davies, K.P., Kalpana, G.V. EMBO J. (2002) [Pubmed]
  24. The t(11;22)(p15.5;q11.23) in a retroperitoneal rhabdoid tumor also includes a regional deletion distal to CRYBB2 on 22q. Besnard-Guérin, C., Cavenee, W., Newsham, I. Genes Chromosomes Cancer (1995) [Pubmed]
  25. Cytokeratin subunits of inclusion bodies in rhabdoid cells: immunohistochemical and clinicopathological study of malignant rhabdoid tumor and epithelioid sarcoma. Shiratsuchi, H., Oshiro, Y., Saito, T., Itakura, E., Kinoshita, Y., Tamiya, S., Oda, Y., Komiyama, S., Tsuneyoshi, M. Int. J. Surg. Pathol. (2001) [Pubmed]
  26. Resistance of a VEGF-producing tumor to anti-VEGF antibody: unimpeded growth of human rhabdoid tumor xenografts. Soffer, S.Z., Kim, E., Huang, J., McCrudden, K., Yokoi, A., Moore, J.T., Manley, C., O'Toole, K., Middlesworth, W., Stolar, C., Yamashiro, D.J., Kandel, J.J. J. Pediatr. Surg. (2002) [Pubmed]
  27. Targeting cyclin D1, a downstream effector of INI1/hSNF5, in rhabdoid tumors. Alarcon-Vargas, D., Zhang, Z., Agarwal, B., Challagulla, K., Mani, S., Kalpana, G.V. Oncogene (2006) [Pubmed]
  28. Second-line chemotherapy with the association of liposomal daunorubicin, carboplatin and etoposide in children with recurrent malignant brain tumors. Fiorillo, A., Maggi, G., Greco, N., Migliorati, R., D'Amico, A., De Caro, M.D., Sabbatino, M.S., Buffardi, F. J. Neurooncol. (2004) [Pubmed]
  29. Absence of immunoperoxidase staining for myoglobin in the malignant rhabdoid tumor of the kidney. Rutledge, J., Beckwith, J.B., Benjamin, D., Haas, J.E. Pediatric pathology / affiliated with the International Paediatric Pathology Association. (1983) [Pubmed]
WikiGenes - Universities